InVitae (NVTA) Set to Announce Quarterly Earnings on Monday

InVitae (NYSE:NVTA) will be announcing its earnings results after the market closes on Monday, February 12th. Analysts expect the company to announce earnings of ($0.55) per share for the quarter.

InVitae (NYSE:NVTA) last posted its earnings results on Monday, November 6th. The medical research company reported ($0.57) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.55) by ($0.02). InVitae had a negative return on equity of 115.25% and a negative net margin of 206.95%. On average, analysts expect InVitae to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Shares of InVitae (NYSE:NVTA) opened at $6.52 on Monday. The company has a market capitalization of $345.20 and a price-to-earnings ratio of -2.56. InVitae has a fifty-two week low of $6.28 and a fifty-two week high of $11.88. The company has a quick ratio of 2.61, a current ratio of 2.61 and a debt-to-equity ratio of 0.33.

A number of analysts have commented on NVTA shares. Zacks Investment Research lowered InVitae from a “hold” rating to a “sell” rating in a report on Thursday, January 4th. BidaskClub lowered InVitae from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd. Benchmark reduced their target price on InVitae from $16.00 to $11.00 and set a “buy” rating for the company in a report on Tuesday, January 16th. Leerink Swann reduced their target price on InVitae from $12.00 to $10.00 and set an “outperform” rating for the company in a report on Tuesday, January 16th. Finally, Ladenburg Thalmann Financial Services started coverage on InVitae in a report on Friday, January 5th. They issued a “buy” rating and a $15.00 target price for the company. Three investment analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. InVitae presently has a consensus rating of “Hold” and a consensus target price of $12.40.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/05/invitae-nvta-set-to-announce-quarterly-earnings-on-monday.html.

InVitae Company Profile

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Earnings History for InVitae (NYSE:NVTA)

Receive News & Ratings for InVitae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InVitae and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply